StocksMedium•10 November 2026•
1 min read
GeneDx Q3 Earnings Beat Estimates at $0.28 Per Share
Key Facts
1GeneDx Holdings reported quarterly earnings of $0.28 per share, significantly beating the Zacks Consensus Estimate of $0.07.
GeneDx Holdings reported quarterly earnings of $0.28 per share for the third quarter. Zacks reported that these results significantly beat the consensus estimate of $0.07 per share. The company stated that its financial performance surpassed analyst expectations for both earnings per share and total revenue.
WGS closed at $62.37 on November 6, 2026, after trading between a low of $58.75 and a high of $66.35 during the session. The reported $0.28 per share represents a decline from the $0.49 reported in the same period last year, yet the company maintained its outperformance relative to market estimates.